Boston Partners’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
VPM
VCM
NAMI
Boston Partners's OMCL Position: Q1 2026 in Review
Boston Partners increased its Omnicell (OMCL) stake by 19% in Q1 2026, buying an estimated $3.51M and bringing the position to 531,305 shares worth $17.8M. The position accounts for 0.02% of the portfolio, ranked #385.
Boston Partners first reported a position in OMCL in Q2 2013 and has held it in 11 quarters since. The position peaked at $20.8M in Q4 2025. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.
- Boston Partners held 531,305 shares of Omnicell worth $17.8M as of Q1 2026.
- Boston Partners bought 83,763 Omnicell shares in Q1 2026, an estimated $3.51M.
- Omnicell made up 0.02% of Boston Partners's portfolio in Q1 2026, its #385 holding.
- Boston Partners first reported a position in Omnicell in Q2 2013 and has held it in 11 quarters since.
- Boston Partners's Omnicell position peaked at $20.8M in Q4 2025.
- 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.